CRISPER/CAS System, a Novel Tool of Targeted Therapy of Drug-Resistant Lung Cancer
Lung cancer (LC) is the most common cause of cancer-related death worldwide. Patients with LC are usually diagnosed at advanced phases. Five-year survival rate in LC patients is approximately 16%. Despite decades of research on LC treatments, clinical outcomes are still very poor, necessitating to d...
Saved in:
Main Authors: | Vahid Akbari Kordkheyli (Author), Mohsen Rashidi (Author), Yasaman Shokri (Author), Samane Fallahpour (Author), Atena Variji (Author), Ehsan Nabipour Ghara (Author), Sayed Mostafa Hosseini (Author) |
---|---|
Format: | Book |
Published: |
Tabriz University of Medical Sciences,
2022-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Development of the COVID-19 Real-Time Information System for Preparedness and Epidemic Response (CRISPER), Australia
by: Emma Field, et al.
Published: (2021) -
Gene editing and therapy - A new tool: CRISPR/Cas9
by: Ashok M. Patil
Published: (2019) -
The Current State and Future of CRISPR-Cas9 gRNA Design Tools
by: Laurence O. W. Wilson, et al.
Published: (2018) -
CRISPR/Cas9: A Potential Life-Saving Tool. What's next?
by: Diana Gulei, et al.
Published: (2017) -
CRISPR-Cas9 System as a Versatile Tool for Genome Engineering in Human Cells
by: Xuelian Wang, et al.
Published: (2016)